Quantbot Technologies’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Quantbot Technologies's IRMD Position: Q1 2026 in Review
Quantbot Technologies increased its iRadimed (IRMD) stake by 19% in Q1 2026, buying an estimated $143K and bringing the position to 8,818 shares worth $849K. The position accounts for 0.03% of the portfolio, ranked #652.
Quantbot Technologies first reported a position in IRMD in Q1 2022 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Quantbot Technologies held 8,818 shares of iRadimed worth $849K as of Q1 2026.
- Quantbot Technologies bought 1,425 iRadimed shares in Q1 2026, an estimated $143K.
- iRadimed made up 0.03% of Quantbot Technologies's portfolio in Q1 2026, its #652 holding.
- Quantbot Technologies first reported a position in iRadimed in Q1 2022 and has held it in 11 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.